224 related articles for article (PubMed ID: 27353564)
21. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE
J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950
[TBL] [Abstract][Full Text] [Related]
22. Pressure effects on α-synuclein amyloid fibrils: An experimental investigation on their dissociation and reversible nature.
Piccirilli F; Plotegher N; Spinozzi F; Bubacco L; Mariani P; Beltramini M; Tessari I; Militello V; Perucchi A; Amenitsch H; Baldassarri E; Steinhart M; Lupi S; Ortore MG
Arch Biochem Biophys; 2017 Aug; 627():46-55. PubMed ID: 28624352
[TBL] [Abstract][Full Text] [Related]
23. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
Koo HJ; Choi MY; Im H
Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
[TBL] [Abstract][Full Text] [Related]
24. Interaction of α-synuclein with Rhus typhina tannin - Implication for Parkinson's disease.
Sekowski S; Ionov M; Abdulladjanova N; Makhmudov R; Mavlyanov S; Milowska K; Bryszewska M; Zamaraeva M
Colloids Surf B Biointerfaces; 2017 Jul; 155():159-165. PubMed ID: 28419945
[TBL] [Abstract][Full Text] [Related]
25. Meclofenoxate Inhibits Aggregation of Alpha-synuclein
Parui A; Biswas S; Roy I
Protein Pept Lett; 2023; 30(5):361-366. PubMed ID: 36880185
[TBL] [Abstract][Full Text] [Related]
26. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
[TBL] [Abstract][Full Text] [Related]
27. Characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase early amyloid-like oligomers and their implication in α-synuclein aggregation.
Torres-Bugeau CM; Ávila CL; Raisman-Vozari R; Papy-Garcia D; Itri R; Barbosa LR; Cortez LM; Sim VL; Chehín RN
J Biol Chem; 2012 Jan; 287(4):2398-409. PubMed ID: 22134915
[TBL] [Abstract][Full Text] [Related]
28. Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure.
Ponzini E; De Palma A; Cerboni L; Natalello A; Rossi R; Moons R; Konijnenberg A; Narkiewicz J; Legname G; Sobott F; Mauri P; Santambrogio C; Grandori R
J Biol Chem; 2019 Apr; 294(14):5657-5665. PubMed ID: 30755483
[TBL] [Abstract][Full Text] [Related]
29. S100A9 Alters the Pathway of Alpha-Synuclein Amyloid Aggregation.
Toleikis Z; Ziaunys M; Baranauskiene L; Petrauskas V; Jaudzems K; Smirnovas V
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360737
[TBL] [Abstract][Full Text] [Related]
30. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
Ghee M; Melki R; Michot N; Mallet J
FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
[TBL] [Abstract][Full Text] [Related]
31. Dependence of alpha-synuclein aggregate morphology on solution conditions.
Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
[TBL] [Abstract][Full Text] [Related]
32. In Vitro Antineoplastic and Antiviral Activity and In Vivo Toxicity of
Zaharieva MM; Dimitrova LL; Philipov S; Nikolova I; Vilhelmova N; Grozdanov P; Nikolova N; Popova M; Bankova V; Konstantinov SM; Zheleva-Dimitrova D; Najdenski HM
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011479
[TBL] [Abstract][Full Text] [Related]
33. Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.
Mohammad-Beigi H; Aliakbari F; Sahin C; Lomax C; Tawfike A; Schafer NP; Amiri-Nowdijeh A; Eskandari H; Møller IM; Hosseini-Mazinani M; Christiansen G; Ward JL; Morshedi D; Otzen DE
J Biol Chem; 2019 Mar; 294(11):4215-4232. PubMed ID: 30655291
[TBL] [Abstract][Full Text] [Related]
34. Modification by glyceraldehyde-3-phosphate prevents amyloid transformation of alpha-synuclein.
Barinova K; Serebryakova M; Sheval E; Schmalhausen E; Muronetz V
Biochim Biophys Acta Proteins Proteom; 2019 Apr; 1867(4):396-404. PubMed ID: 30639428
[TBL] [Abstract][Full Text] [Related]
35. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes.
Munishkina LA; Phelan C; Uversky VN; Fink AL
Biochemistry; 2003 Mar; 42(9):2720-30. PubMed ID: 12614167
[TBL] [Abstract][Full Text] [Related]
36. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
[TBL] [Abstract][Full Text] [Related]
37. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
Lee JH; Lee IH; Choe YJ; Kang S; Kim HY; Gai WP; Hahn JS; Paik SR
Biochem J; 2009 Mar; 418(2):311-23. PubMed ID: 19007333
[TBL] [Abstract][Full Text] [Related]
38. Structure based aggregation studies reveal the presence of helix-rich intermediate during α-Synuclein aggregation.
Ghosh D; Singh PK; Sahay S; Jha NN; Jacob RS; Sen S; Kumar A; Riek R; Maji SK
Sci Rep; 2015 Mar; 5():9228. PubMed ID: 25784353
[TBL] [Abstract][Full Text] [Related]
39. Rationally designed helical peptidomimetics disrupt α-synuclein fibrillation.
Bavinton CE; Sternke-Hoffmann R; Yamashita T; Knipe PC; Hamilton AD; Luo J; Thompson S
Chem Commun (Camb); 2022 Apr; 58(33):5132-5135. PubMed ID: 35380562
[TBL] [Abstract][Full Text] [Related]
40. Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: Implications for Parkinson's disease.
Fazili NA; Naeem A
Biochimie; 2015 Jan; 108():178-85. PubMed ID: 25461276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
